Oliver Luxxe Assets’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-12,019
Closed -$957K 162
2023
Q2
$957K Buy
12,019
+467
+4% +$33.7K 0.24% 97
2023
Q1
$835K Buy
11,552
+742
+7% +$57.8K 0.22% 99
2022
Q4
$890K Buy
10,810
+284
+3% +$23.4K 0.25% 91
2022
Q3
$823K Buy
10,526
+196
+2% +$15.7K 0.26% 89
2022
Q2
$699K Buy
+10,330
New +$721K 0.21% 105

Other funds holding ACHC

Oliver Luxxe Assets's ACHC Position: Q3 2023 in Review

Oliver Luxxe Assets sold out of Acadia Healthcare (ACHC) in Q3 2023, closing a stake of 12,019 shares — an estimated $957K sold.

Oliver Luxxe Assets first reported a position in ACHC in Q2 2022 and held it in 5 quarters. The position peaked at $957K in Q2 2023. 293 funds tracked by Wall St. Rank hold ACHC as of Q3 2023.

  • Oliver Luxxe Assets reported no remaining Acadia Healthcare position as of Q3 2023 after selling out during the quarter.
  • Oliver Luxxe Assets sold 12,019 Acadia Healthcare shares in Q3 2023, an estimated $957K.
  • Oliver Luxxe Assets first reported a position in Acadia Healthcare in Q2 2022 and held it in 5 quarters.
  • Oliver Luxxe Assets's Acadia Healthcare position peaked at $957K in Q2 2023.
  • 293 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2023.

Based on Oliver Luxxe Assets's 13F filing for Q3 2023, filed 9 Nov 2023.